CompletedNCT02563769
Safety of Clavulanic Acid Combined With Cocaine
About this title
Read the official source — NCT02563769Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: October 24, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Temple University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02563769
- Official title
Show the full official title
Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Clavulanic Acid
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Temple University, a university.
Did this study involve medication?
Yes. The study involved medication, including Clavulanic acid, Intravenous cocaine and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
